Filing Flows › Apyx Medical (APYX) › Q2 2026
Apyx Medical (APYX) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 6, 2026
Apyx Medical (APYX) reported revenue of $13.9M for the second quarter 2026 (Q2 2026), +22% from a year earlier and +11% from the quarter before. Operating margin was -13.0%, net loss $3.1M (22.1% of revenue).
Apyx Medical, Q2 2026: revenue $13.9M (+22% year over year), operating margin -13.0%, net loss $3.1M, operating cash flow −$3.5M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $13.9M | +11% | +22% |
| Operating profit | −$1.8M | — | — |
| Net earnings | −$3.1M | — | — |
| Operating cash flow | −$3.5M | — | — |
What changed
Revenue was $13.9M in Q2 2026, up 22% year over year and up 11% from the previous quarter.
Gross margin was 63.9%, up 1.6 points from Q2 2025. Operating costs exceeded revenue by $1.8M, an operating margin of -13.0%. Operating expenses grew 11% against revenue growth of 22%. The fastest-growing cost line was SG&A (+24%). The quarter ended with a net loss of $3.1M, wider than the previous quarter's $2.1M loss.
Operating cash flow was −$3.5M. Non-cash charges added back $196K of depreciation and amortization and $1.1M of share-based compensation. Working capital and other items used $1.7M. Capital expenditures of $66K exceeded it, leaving free cash flow of −$3.6M.
Questions
What was Apyx Medical's revenue in the second quarter 2026?
Apyx Medical (APYX) reported revenue of $13.9M for the second quarter 2026 (Q2 2026), +22% from a year earlier and +11% from the quarter before.
Was Apyx Medical profitable in the second quarter 2026?
Operating loss was $1.8M (-13.0% of revenue) and net loss $3.1M.
Source: Apyx Medical 10-Q on SEC EDGAR.